Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon alpha2 (IFNα2) is a cytokine belonging to the type I interferon family. It is produced and secreted by cells, particularly leukocytes, in response to viral infection. IFNα2 plays a crucial role in the innate immune response by inhibiting viral replication and modulating immune cell activity.
Binds type I interferon receptors (IFNAR1 and IFNAR2) → activates JAK/STAT pathway → induces expression of interferon-stimulated genes (ISGs) leading to antiviral state and immunomodulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon alpha 2 (IFNα2).